Prof. Dr. Jiri Litzman – FDA Inspection, May 17, 2018

Record Details

This FDA Inspection record concerns Prof. Dr. Jiri Litzman, with an inspection on May 17, 2018, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company: Prof. Dr. Jiri Litzman
Inspection Date: May 17, 2018
Product Type: Biologics
Office: Center for Biologics Evaluation and Research
Person: Richard A. Lyght (Issuing Officer)

View Company Profile

ID · ecc82ff9-bb24-43b7-8072-d635d7352ff4

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number: 1053042
FDA center: Biologics
Project area: Blood and Blood Products
Outcome: Form 483 issued

FDA Citations

21 CFR 312.60FD-1572, protocol compliance

Full citation text and observation details available on the Dashboard.

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Prof. Dr. Jiri Litzman

FDA Inspection

Prof. Dr. Jiri LitzmanMay 17, 2018